Research Options:

Week of Expected Pricing Pending
Company Name CURANEX PHARMACEUTICALS INC
Proposed Ticker CURX
CUSIP N/A
Business Description Curanex is a developmental stage pharmaceutical company dedicated to discovering, developing and commercializing innovative botanical drugs to treat patients suffering from inflammatory diseases. Our mission is to address significant unmet medical needs and improve patients’ lives by harnessing the power of natural substances. We are dedicated to discovering, developing and commercializing botanical medicines for treating patients with immune and inflammatory diseases and to develop therapies that may offer potential benefits to patients with unmet clinical needs in various fields, such as autoimmune diseases, metabolic diseases and viral infections.
Lead Underwriter Dominari Securities LLC, Revere Securities LLC
Co-Managers N/A
Initial Shares 2,000,000
Revised Initial Shares N/A
Initial Price $4.00-$6.00
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 

   
  © 2024 ICE Data Services. All rights reserved.